Case Study: VaxArt improves norovirus vaccine safety monitoring with ObvioHealth's virtual clinical trial platform

VaxArt - Customer Case Study

VaxArt needed a way to evaluate the safety of its oral norovirus vaccine, with a specific challenge in quickly identifying subjects who experienced severe reactogenicity symptoms immediately after dosing. To address this, they partnered with the vendor ObvioHealth.

ObvioHealth implemented a solution using their mobile app for electronic patient-reported outcomes (ePRO). Participants completed daily diaries in the app for seven days, and the system instantly alerted the safety team to any reports of severe symptoms for rapid follow-up. The solution also included alerts for site staff to prompt participants who had not completed their diaries, ensuring high compliance and timely data capture. This approach allowed for continuous, remote safety monitoring and efficient data collection.

VaxArt